Regenerative Surgical Treatment of Peri-implant Defects
1 other identifier
interventional
44
1 country
1
Brief Summary
Does submerged healing of implants improve clinical and radiologic outcomes for the treatment of peri-implantitis? A number of recent systematic reviews have shown that the prevalence of periimplantitisin the population is high. Nevertheless, there appears to be no consensus on treatment standards for the management of peri-implant diseases. Also, the significant variation in the empirical use of the available therapeutic modalities seems to result in moderately effective treatment outcomes. Animal and human case series-studies have shown improved outcomes when using a submerged healing approach. However, there seems to be no randomized controlled clinical studies comparing submerged/non-submerged healing efficacy for the treatment of peri-implantitis. Since current modalities for the treatment of peri-implantitis seem to result inmoderately effective outcomes, there is an urgency to investigate treatment strategies that will result in improved patient's benefits in terms of health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2020
CompletedFirst Posted
Study publicly available on registry
June 19, 2020
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedSeptember 29, 2021
September 1, 2021
8 months
June 15, 2020
September 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Changes marginal bone level
measured on periapical X-rays, from the shoulder of the implant to the bottom of the bone defect next to the implant at the mesial and distal surfaces. Mean marginal bone levels between mesial and distal measurements will be calculated.
baseline, 6 and 12 months
Secondary Outcomes (8)
Changes Probing pocket depth
baseline, 6 and 12 months
Changes Clinical attachment level
baseline, 6 and 12 months
Change Reccesion
baseline, 6 and 12 months
Change Keratinized mucosa
baseline, 6 and 12 months
Change blending on probing
baseline, 6 and 12 months
- +3 more secondary outcomes
Study Arms (2)
Test group
EXPERIMENTALsubmerged healing treatment of peri-implantitis using guided bone regeneration with a bone substitute and a resorbable membrane.
Control group
EXPERIMENTALnon submerged healing treatment of peri-implantitis using guided bone regeneration with a bone substitute and a resorbable membrane.
Interventions
Full thickness buccal and lingual flaps will be performed. After debridement of the defect using hand and ultrasonic instruments and implant surface decontamination using titanium brushes (TiBrush®) and saline Regenerative treatment will be performed only in the intrabony component of type 1 peri-implant defects. Guided bone regeneration using a bone substitute (Bio-oss®) and a resorbable membrane (bio-gide®) will be performed in the intrabony and dehiscenses areas of the defect. The surgeon will be blinded to the assignment of treatment until it is time to close the flaps.
Eligibility Criteria
You may qualify if:
- Age ≥18 years.
- Systemically healthy patients.
- Presence of at least 1 implant diagnosed with peri-implantitis (peri-implant probing pocket depth ≥6 mm in at least 1 aspect of the implant with bleeding and/or suppuration on probing and radiographically documented marginal bone loss ≥3mm) according to Renvert et al. (2018), after non-surgical therapy of periimplantitis, and a 4mm deep intrabony component.
- Absence of mobility of the implants.
- Individual implant-supported crown or partial fixed implant supported restoration (removable prosthesis will be excluded).
- Patient's smoking ≤ 10 cigarettes/day.
You may not qualify if:
- Non-removable prostheses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Santiago de Compostelalead
- Osteology Foundationcollaborator
Study Sites (1)
Master Periodoncia. Facultad odontología
Santiago de Compostela, A Coruña, 15782, Spain
Related Publications (3)
Schwarz F, Herten M, Sager M, Bieling K, Sculean A, Becker J. Comparison of naturally occurring and ligature-induced peri-implantitis bone defects in humans and dogs. Clin Oral Implants Res. 2007 Apr;18(2):161-70. doi: 10.1111/j.1600-0501.2006.01320.x.
PMID: 17348880RESULTSchwarz F, Sahm N, Schwarz K, Becker J. Impact of defect configuration on the clinical outcome following surgical regenerative therapy of peri-implantitis. J Clin Periodontol. 2010 May;37(5):449-55. doi: 10.1111/j.1600-051X.2010.01540.x. Epub 2010 Mar 24.
PMID: 20374416RESULTRoccuzzo M, Bonino F, Bonino L, Dalmasso P. Surgical therapy of peri-implantitis lesions by means of a bovine-derived xenograft: comparative results of a prospective study on two different implant surfaces. J Clin Periodontol. 2011 Aug;38(8):738-45. doi: 10.1111/j.1600-051X.2011.01742.x. Epub 2011 Jun 2.
PMID: 21635278RESULT
Study Officials
- STUDY DIRECTOR
Santiago Mareque
University of Santiago de Compostela
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator - Juan Blanco Carrión
Study Record Dates
First Submitted
June 15, 2020
First Posted
June 19, 2020
Study Start
April 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2022
Last Updated
September 29, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share